TRCT
PHXM

Tower Research Capital (TRC)’s PHAXIAM Therapeutics S.A.. American Depositary Shares PHXM Stock Holding History

Tower Research Capital (TRC)’s Portfolio PHXM Stock Details PHXM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-32
Closed -$1K – 6757
2021
Q4 		$1K Buy
32
+2
+7% +$67 ﹤0.01% 5939
2021
Q3 		$2K Buy
+30
New +$1.68K ﹤0.01% 5331

Other funds holding PHXM

AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Jane Street
Jane Street New York $93.1B AUM 61.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $3.03B AUM 104.56% 1-Year Est. Return